Re: Bevacizumab plus Interferon alfa-2a for Treatment of Metastatic Renal Cell Carcinoma: A Randomised, Double-Blind Phase III Trial
Shahrokh F. Shariat, Christian Bolenz, Pierre I. KarakiewiczVolume:
54
Year:
2008
Language:
english
Pages:
2
DOI:
10.1016/j.eururo.2008.07.026
File:
PDF, 105 KB
english, 2008